Allstate (NYSE:ALL – Get Free Report) had its target price upped by investment analysts at Mizuho from $255.00 to $272.00 in a research note issued on Thursday,Benzinga reports. The firm currently has an “outperform” rating on the insurance provider’s stock. Mizuho’s price objective would suggest a potential upside of 8.66% from the stock’s current price.
Several other analysts also recently weighed in on ALL. Barclays lifted their price target on shares of Allstate from $203.00 to $213.00 and gave the company an “underweight” rating in a research note on Tuesday. Citigroup raised their price target on Allstate from $221.00 to $226.00 and gave the company a “neutral” rating in a research note on Friday, May 1st. Weiss Ratings restated a “buy (a-)” rating on shares of Allstate in a report on Thursday, June 18th. HSBC lowered shares of Allstate from a “buy” rating to a “hold” rating and upped their price objective for the stock from $244.00 to $264.00 in a research note on Monday. Finally, Morgan Stanley increased their target price on shares of Allstate from $215.00 to $240.00 and gave the stock an “equal weight” rating in a report on Monday. Three equities research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Allstate presently has an average rating of “Moderate Buy” and an average price target of $246.32.
View Our Latest Research Report on Allstate
Allstate Price Performance
Allstate (NYSE:ALL – Get Free Report) last released its earnings results on Wednesday, April 29th. The insurance provider reported $10.65 earnings per share for the quarter, beating the consensus estimate of $7.31 by $3.34. Allstate had a return on equity of 42.66% and a net margin of 17.81%.The firm had revenue of $16.94 billion for the quarter, compared to the consensus estimate of $15.24 billion. During the same quarter in the previous year, the company posted $3.53 EPS. The company’s revenue for the quarter was up 3.0% compared to the same quarter last year. Equities analysts forecast that Allstate will post 29.8 EPS for the current year.
Insider Buying and Selling
In other Allstate news, COO Mario Rizzo sold 18,578 shares of the business’s stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of $218.80, for a total transaction of $4,064,866.40. Following the sale, the chief operating officer owned 82,227 shares of the company’s stock, valued at approximately $17,991,267.60. The trade was a 18.43% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Mark Q. Prindiville sold 1,550 shares of the company’s stock in a transaction that occurred on Friday, May 22nd. The shares were sold at an average price of $216.27, for a total transaction of $335,218.50. Following the transaction, the insider owned 27,558 shares in the company, valued at $5,959,968.66. The trade was a 5.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 22,353 shares of company stock worth $4,851,560 in the last three months. Corporate insiders own 1.55% of the company’s stock.
Institutional Trading of Allstate
Large investors have recently added to or reduced their stakes in the company. MV Capital Management Inc. acquired a new position in Allstate in the 4th quarter worth approximately $25,000. Dorato Capital Management purchased a new stake in shares of Allstate in the 4th quarter valued at $27,000. Navalign LLC purchased a new stake in shares of Allstate in the 4th quarter valued at $27,000. Evolution Wealth Management Inc. lifted its position in Allstate by 7,000.0% during the first quarter. Evolution Wealth Management Inc. now owns 142 shares of the insurance provider’s stock valued at $29,000 after purchasing an additional 140 shares during the period. Finally, Marshall & Sterling Wealth Advisors Inc. purchased a new stake in Allstate in the first quarter valued at $30,000. Hedge funds and other institutional investors own 76.47% of the company’s stock.
Key Stories Impacting Allstate
Here are the key news stories impacting Allstate this week:
- Positive Sentiment: Allstate announced a quarterly dividend of $1.08 per share, signaling continued capital returns to shareholders and reinforcing the company’s strong cash generation. Allstate announces quarterly dividend payable Oct. 1, 2026
- Positive Sentiment: Keefe, Bruyette & Woods raised its price target on Allstate to $255 from $242, suggesting the stock still has modest upside from recent levels and may be undervalued on earnings. Analyst price target raise coverage
- Positive Sentiment: A report said Allstate is having a relatively quiet catastrophe year, which could help lower claims costs and support stronger second-quarter profitability. Allstate Is Having a Quiet Catastrophe Year. Here’s Why That Could Power a Strong Q2.
Allstate Company Profile
Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.
The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.
See Also
- Five stocks we like better than Allstate
- Catching the AI Wave: DigitalOcean Reels in AI Whales
- Rivian’s 75 Million-Share Offering Turns the R2 Growth Story Into a Dilution Test
- Sony Is Going All-Digital—But Investors Should Watch This Instead
- Scotiabank Sees a New Growth Story for Cloudflare
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
